Johanna Friedl Naderer Dyne Therapeutics, Inc. (DYN) insider trading activity

Johanna Friedl Naderer is Chief Commercial Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 96,057 shares of DYN, which is worth approximately $1.1 Million. The most recent transaction as insider was on Mar 13, 2025, when has been sold 143 shares (Common Stock) at a price of $12.12 per share, resulting in proceeds of $1,733. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.1K

0.15% 3M change

n/a 12M change

Total Value Held $1.1 Million

Johanna Friedl-Naderer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 13 2025	SELL Open market or private sale	$1,733 $12.12 p/Share	143 Reduced 0.15%	96,057 Common Stock
Dec 04 2024	BUY Grant, award, or other acquisition	-	37,800 Added 28.21%	96,200 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	58,400 Added 50.0%	58,400 Common Stock

Also insider at

VIR

Vir Biotechnology, Inc. Healthcare

EVP & Chief Operating Officer